Merck Sharp & Dohme recalls
FDA enforcement reports naming Merck Sharp & Dohme as the recalling firm.
- Recall reports
- 5
- Class I (serious)
- 1
- Most recent report
- Dec 31, 2025
- Dec 31, 2025Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufac…Drug · Merck Sharp & Dohme LLCPresence of particulate matter: potential presence of metal particulates in the product.Class II
- Dec 31, 2025Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets…Drug · Merck Sharp & Dohme LLCPresence of particulate matter: potential presence of metal particulates in the product.Class II
- Apr 13, 2022Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, package…Drug · MERCK SHARP & DOHME CORPPresence of foreign substance: Presence of stainless steel particulates in tablets.Class II
- Nov 10, 2021Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx onlyDrug · MERCK SHARP & DOHME CORPPresence of Particulate Matter: Identified as Glass ParticlesClass I
- Jan 13, 2021Zerbaxa (ceftolozane and tazobactam) 1Drug · Merck Sharp & DohmeLack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results…Class II